|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
9,610,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.72 - $0.72 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Edesa Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for inflammatory and immune-related diseases. Co.'s primary product candidates include: EB05, which is a monoclonal antibody therapy for the treatment for Acute Respiratory Distress Syndrome in COVID-19 patients; and EB01, which is a secretory phospholipase 2 (sPLA2) inhibitor for the topical treatment for chronic allergic contact dermatitis, a potentially debilitating condition and occupational illness. Co.'s EB02 drug candidate represents a potential extension of its sPLA2 anti-inflammatory technology. Co.'s product candidate EB06, is a monoclonal antibody candidate.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
5,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$20,000 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,644 |
449,767 |
|
- |
|
Marshall Patrick |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
52,666 |
|
- |
|
Chypyha Joan |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
11,029 |
|
- |
|
Sistilli Carlo |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,001 |
30,417 |
|
- |
|
Liu Da David |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,501 |
5,501 |
|
- |
|
Macdonald Sean Arthur |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,001 |
22,054 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
263,200 |
442,123 |
|
- |
|
Weiler Peter J. |
Chief Financial Officer |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
|
- |
|
Brooks Michael J |
President |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
207,201 |
224,870 |
|
- |
|
Olson Charles V |
Director |
|
2025-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
11,000 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,392 |
178,923 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,784 |
172,531 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,339 |
166,747 |
|
- |
|
Sistilli Carlo |
Director |
|
2025-02-12 |
4 |
A |
$1.92 |
$19,999 |
D/D |
10,416 |
10,416 |
|
- |
|
Marshall Patrick |
Director |
|
2025-02-12 |
4 |
A |
$1.92 |
$79,999 |
D/D |
41,666 |
41,666 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,264 |
160,408 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,476 |
152,144 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,420 |
143,668 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,630 |
137,248 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
132,618 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,055 |
129,318 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,317 |
126,263 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,015 |
122,946 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,785 |
118,931 |
|
- |
|
Nijhawan Pardeep |
Chief Executive Officer |
|
2024-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,083 |
114,146 |
|
- |
|
112 Records found
|
|
Page 1 of 5 |
|
|